Immunotherapy of glioblastoma: current strategies and challenges in tumor model development

B Majc, M Novak, N Kopitar-Jerala, A Jewett, B Breznik - Cells, 2021 - mdpi.com
Glioblastoma is the most common brain malignant tumor in the adult population, and
immunotherapy is playing an increasingly central role in the treatment of many cancers …

[HTML][HTML] Recent advances in organotypic tissue slice cultures for anticancer drug development

L He, C Deng - International journal of biological sciences, 2022 - ncbi.nlm.nih.gov
Organotypic tissue slice culture is established from animal or patient tissues and cultivated
in an in vitro ecosystem. This technique has made countless contributions to anticancer drug …

Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases

KM Sullivan, X Jiang, P Guha, C Lausted, JA Carter… - Gut, 2023 - gut.bmj.com
Objective Programmed cell death protein 1 (PD-1) checkpoint inhibition and adoptive
cellular therapy have had limited success in patients with microsatellite stable colorectal …

Mobilization of CD8+ T Cells via CXCR4 Blockade Facilitates PD-1 Checkpoint Therapy in Human Pancreatic Cancer

YD Seo, X Jiang, KM Sullivan, FG Jalikis… - Clinical Cancer …, 2019 - AACR
Purpose: Pancreatic ductal adenocarcinoma (PDA) is rarely cured, and single-agent
immune checkpoint inhibition has not demonstrated clinical benefit despite the presence of …

Engineering T cells to enhance 3D migration through structurally and mechanically complex tumor microenvironments

ED Tabdanov, NJ Rodríguez-Merced… - Nature …, 2021 - nature.com
Defining the principles of T cell migration in structurally and mechanically complex tumor
microenvironments is critical to understanding escape from antitumor immunity and …

Calcium channel blockers potentiate gemcitabine chemotherapy in pancreatic cancer

DR Principe, AF Aissa, S Kumar… - Proceedings of the …, 2022 - National Acad Sciences
There is currently no effective treatment for pancreatic ductal adenocarcinoma (PDAC).
While palliative chemotherapy offers a survival benefit to most patients, nearly all will …

[HTML][HTML] Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses

KJ Brempelis, CM Cowan, SA Kreuser… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Background Though currently approved immunotherapies, including chimeric antigen
receptor T cells and checkpoint blockade antibodies, have been successfully used to treat …

Colorectal Cancer Metastases in the Liver Establish Immunosuppressive Spatial Networking between Tumor-Associated SPP1+ Macrophages and Fibroblasts

A Sathe, K Mason, SM Grimes, Z Zhou, BT Lau… - Clinical Cancer …, 2023 - AACR
Purpose: The liver is the most frequent metastatic site for colorectal cancer. Its
microenvironment is modified to provide a niche that is conducive for colorectal cancer cell …

Organotypic tumor slice cultures provide a versatile platform for immuno-oncology and drug discovery

R Sivakumar, M Chan, JS Shin, N Nishida-Aoki… - …, 2019 - Taylor & Francis
Organotypic tumor slices represent a physiologically-relevant culture system for studying the
tumor microenvironment. Systematic characterization of the tumor slice culture system will …

XP-524 is a dual-BET/EP300 inhibitor that represses oncogenic KRAS and potentiates immune checkpoint inhibition in pancreatic cancer

DR Principe, R Xiong, Y Li… - Proceedings of the …, 2022 - National Acad Sciences
Pancreatic ductal adenocarcinoma (PDAC) is associated with extensive dysregulation of the
epigenome and epigenetic regulators, such as bromodomain and extraterminal motif (BET) …